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FOR most of the causes of death which affect both sexes males register higher
rates than females, and for only about 5 per cent of the total deaths of males at
ages 55-74 in England and Wales does the corresponding female death rate exceed
that ofthe males.
An example ofapparent female susceptibilitywhichwasnoticedwhenstatistics
ofdeaths by sex, age and cause began to be analysed was seen in whooping cough.
In 1936-39 when deaths from that disease were averaging about 1500 annually
the female/male sex ratio for death rates in the first year of life was about 1F2,
increasing to 1.5 and over as age advanced. Amongst possible reasons suggested
for the female excess were higher risk of a fatal issue amongst female children
contracting the disease and a greater danger to females of catching the disease
from childrenwho hadtobelooked afterbythem. Sincethenpreventive measures
including inoculation have reduced the annual deaths to about 20, but since
notifications of whooping cough are being recorded by sex and age, about 2500
annually, it is possible to ascertain the sex differential in rates of incidence. A
female excess is found to be present from the first years of life and to increase
from 5 per cent to over 100 per cent in adults, just as was the case for death
rates in pre-immunisation years. This is shown in Table I for the period 1957-66.
TABLE I.-Sex-ratio of Whooping Cough Notifications in England and
Wales in 1957-66 at Different Ages
Female/male ratios at ages:
0- 1- 5- 10- 15- 25 and over
Whooping cough (056) . 1-05 1-13 12 1 1-22 1-75 2-08
The trend of the rates suggests differential exposure of the sexes to cross-
infection as the reason rather than a genetic factor located in the X-chromosomes
which would be expected to operate fairly uniformly from the start of life, but
this is conjectural.
This example of whooping cough poses similar problems for other diseases
where females suffer higher rates of dying than males at certain ages, and the
present study examines the age patterns of the sex ratios for such diseases shown
by the mortality statistics of England and Wales and other countries where the
information is available.
Table II lists the diseases affecting organs not peculiar to females which have
female/male sex-ratios of their death rates in England and Wales in excess of
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unity at some or all ages after 35. The ratios are between the mean annual death
rates in the period 1963-66, that is the total deaths divided by the total population
at risk, for each sex. For four of the 18 groups a longer period of years has been
used to eliminate effects of chance year-to-year variations in annual deaths when
the numbers ofthese are small. For convenience the last column shows an Index
defined as 100 times the average of the sex-ratios at ages 45-54, 55-64 and 65-74.
The magnitude of the indices ranges from 337 to 100 and the changes in the
sex-ratio according to age are of several kinds, and the 18 diseases have been
grouped accordingly for the sake of clarity.
In a developed society in times of peace differences in risks of death from
specific diseases to which the two sexes are exposed may be of importance in some
occupational groups but they contribute little to the overall differences in sex-
ratios in the population as a whole. The dangers of childbearing have become
inconsiderable as causes of death, but for certain cancers and disorders of the
endocrine and biliary system, diseases of the blood-forming organs, rheumatoid
arthritis and some circulatory and nervous conditions females appear to be more
vulnerable than males. In some cases this is presumably due to peculiarities in
the control exercised by genes in the X-chromosomes ofwhich an extra one occurs
in females. For example, more demands are made upon the thyroid, pituitary
and haemic system by the female organism, and any enzyme control from genes
in the extra chromosome peculiar to women may differ in some way from that
exercised by genes in the other chromosomes which occur in the cells of both
sexes. It is hardly surprising that at least five ofthe diseases in Table II concern
the endocrine glands, three are affections ofthe blood and blood vessels and three
of the liver and biliary systems.
Four groups of malignant neoplasms appear in the list and their association
with non-malignant conditions of the same organs may furnish some clues to the
genetic factors responsible for the high female susceptibility to those particular
cancers. These are discussed in detail below but the table shows that the indices
for the cancer groups range from 182 to 104, and that in behaviour ofthe sex-ratio
according to age they have nothing in common. For thyroid cancer female
excess is high throughout life, for the biliary passages it appears only after 45,
for intestine it disappears after 60 and for malignant melanoma of the skin it
diminishes with advancing age.
Diseases showing excess offemale over male death rates
Thyroiddiseases otherthan cancer (internationalnumbers 250-254) show ahigher
level of female excess in rates of dying than any other group, with ratios around
4 except for a temporary fall between ages 45 and 60 which may be connected
with the menopause. This high susceptibility of women to disorders resulting in
death derives presumably from genes in the additional X-chromosome since the
gland has some important functions connected with childbearing and peculiar
to females.
Cancer of the thyroid (194) manifests a similar female excess at each age with
sex-ratios around 2 but with a depression at ages 45-60 as for the other thyroid
diseases. The index, 182, compares with 337 in that group. Since the cancer
death rates are not very large a longer period of 14 years (1950-63) has been used,
the data for England and Wales being extracted from the international compila-
tions by Segi and Kurihara (1966). At ages 25-34 the sex-ratio was 2-02, and at
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TABLE II.-Diseases with Female Susceptibility Indicated by Death Rates
in England and Wales in 1963-66
Disease group
Thyroid diseases (except cancer)
Cancer of thyroid* .
Rheumatoid arthritis
Chronic rheumatic heart
Obesity
Diseases of gall bladder and ducts
(except cancer)
Subarachnoid haemorrhage
Anaemias, purpura, diseases of
spleen etc.
Pituitary and adrenal diseasest
Asthma
Cancer of intestines except rectum*
Multiple sclerosis
Cancer of biliary passages
Diabetes mellitus
Malignant melanoma of skin
Chronic endocarditis, not
rheumatic and not aortic .
valvest
Liver diseases except cirrhosis
and cancer
Diseases of veins, embolism
Ratio, female/male death rate
Inter- at the specified age-group
national , A__ _
No. 35- 45- 55- 65- 75+
250-4
194
722
410-6
287
584-6
High female/male ratios at most ages
. 4-42 2-83 3-84 4-93 4-35 .
. 2-42 1-62 1-93 2-03 2-53 .
. 3-60 1-86 2-06 2-21 2-78 .
. 1-45 1-56 1-57 1-44 1-51 .
2-51 2-19 2-00 2-53 2-46 .
1-45 1-47 1-46 1-19 1-12
330 . 1-12 1-30 1-24 1-48 1-67 .
290-3, 296, . 1-65 1-45 1-17 1-18 1-16 .
.298-9
. 272, 274
. 241
. 152-3
. 345
. 155-1-
155-8
. 260
. 190
. 421-0,
. 421-2,
-421-3, 4
-580, 582-3
. 460-6
High female/male ratios until age 60
1-59 1-53 1-15 0-86 0-67
. 1-54 1-31 1-10 0-87 0-96 .
. 1-20 1-20 1-05 0-87 0-99 .
. 1-61 1-56 1-31 0-96 0-82 .
High female/male ratios after 55 or 65
. 0-59 1-07 1-36 1-29 1-30 .
- 0-55 0-74 1-19 1-42 1-14
Moderate female excess at most ages
1-27 1-11 1-09 1-08 1-00 .
1-04 1-15 0-99 1-07 1-28 .
, 1-04 1-26 0-99 1-03 0-81 .
1-57 1-14 0-85 1-00 1-08
Index
100 x
average
ratio
at 45-74
337
182
208
152
224
137
134
127
118
109
104
127
124
112
109
107
109
100
* Averages for 10 years 1957-66.
t Averages for 14 years 1950-63.
successive 5-year age groups from 35-39 onwards the ratios were 2-6, 2-5, 1-5, 1-7,
1-7, 2-2, 1-9, 2-1, 2-1, 2-3, 3-4, revealing more clearly the drop in ratio after 45 to
1-5 and 1-7 and a return to the average 2-2 level after age 60. In Fig. 1 the death
rates for each sex in England and Wales are depicted on a logarithmic scale so
that the vertical gaps between the two curves conveniently represent the actual
female/male ratios at each age. The gap is seen to narrow after age 40 and widen
again later without obvious disturbance of the male mortality curve, indicating a
temporary lessening of female susceptibility between 40 and 60.
In Table III the mean annual death rates of women from thyroid cancer per
10 million at risk in 1954-61 are shown for 13 countries of Europe and the ratios
of these rates to those of men are compared at different ages. The countries
are ranked in descending order ofthe index in the last column, defined as before as
100 times the mean of the 3 ratios between 45 and 74. The indices range from
313 in Ireland to 130 in Austria, and it is remarkable that the first seven countries
are all in northern Europe whereas five ofthe six countries with indices below 175
are countries in mid-Europe, the only one out ofplace being Norway (142). There
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seems to be a climatic factor involved with strong effect upon female vulnerability
to the disease. The higher ratios in the north are not merely due to higher female
death rates with the male rates unaffected; there are in fact two countries,
Switzerland and Austria, with much the highest female rates at every age up to
75 but also the lowest female/male indices, these countries being mountainous
with high prevalence of simple goitre. The averages of the rates for each sex
in four parts ofEurope are shown in Table IV. The Swiss and Austrian rates far
exceed those of the other areas for each sex. For males the Scandinavian rates
exceed those of Britain at all ages and the mid-Europe rates at all ages except
55-64, but the British rates show no excess over mid-Europe. For females both
Scandinavian and British rates exceed the mid-European at ages over 45 and a
strong northern excess is evident after 65.
That the female excess in death rates is not to be explained by sex differences
in fatality is shown by the incidence rates derived from cancer registration in
Denmark during 1943-57 (Clemmesen, 1964) which yield the followingfemale/male
sex-ratios at successive age groups from 35-44: 1-6, 1-9, 5-0, 2-4, 2-9. These would
lead to an index of 310 compared with 200 for death rates in that country.
TABLE III.-Death Rates of Womenfrom Cancer of the Thyroid in 1954-61
and Sex-ratios in 13 Countries
Mean annual female Ratios to male rates
rates per 10 million at specified ages Index
-' ----------A at
Countries 35- 45- 55- 65- 75+ 35- 45- 55- 65- 75+ 45-74
Eire and N. Ireland . . 4 15 34 80 84 1-8 2-7 3-3 3-4 3-2 . 313
Sweden . . . 4 8 21 89 136 1-1 1-9 1-7 3-0 3-7 . 220
Scotland . . 2 11 27 69 89 . 1-5 0-9 2-4 2-9 1-6 . 207
Denmark . . . . 2 12 34 56 140 1-7 2 -2 2-4 1-4 2-4 200
Finland . . . 5 12 30 51 96 1-0 1-3 1-8 2-7 1-6 . 193
England and Wales . . 2 8 21 45 74 2-0 1-8 1-9 1-9 3-6 . 189
Netherlands and Belgium . 3 9 21 47 62 2-1 1-6 1-8 2-0 2-9 . 177
France . . . . . 2 6 20 38 48 . 1-7 1-4 1-4 2-3 2-2 168
Italy. . . . . . 3 9 23 47 55 . 1-4 1-3 1-5 2-1 1-8 . 161
Germany, F.R. . . . . 3 12 29 62 82 . 1-2 1-5 1-2 1-6 2-1 . 142
Norway* . . . . . 2 7 25 66 188 . 1-9 1-1 1-6 1-6 2-7 7 142
Switzerland . . . . 5 36 62 126 149 . 3-4 2-0 1-0 1-1 1-5 . 138
Austria . . . . . 8 21 48 125 199 1-6 1-3 1-1 1 6 1-8 . 130
* Based on 12 years 1952-63
TABLE IV.-Thyroid Cancer Death Rates in Parts of Europe, Mean Annual
per 10 million in 1954-61 (Averagesfor Countries in Group)
35- 45- 55- 65- 75+
Males Index
A 45-74
SwitzerlaAd and Austria . . . 3-1 17-6 54 95 126
Other mid-Europe . . . . 1-8 6-2 17 26 48
British Isles . . . . . 1-8 6-3 11 24 31
Scandinavian countries . . 2-6 7-0 15 36 49
Females
Switzerland and Austria . . . 6-3 28-8 50 125 174 . 130
Other mid-Europe . . . 2-8 9-0 23 48 62 . 158
British Isles . . . . 2-5 11-5 29 69 82 . 244
Scandinavian countries . . . 3-3 10-0 28 74 124 . 170
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Rheumatoid arthritis (722) shows evidence of high female susceptibility with
sex-ratios of 3'6 at 35-44, around 2 between 45 and 74 and 2-8 at ages 75 and over
(index 218). The causes of this disease are still obscure and the reputed roles of
heredity, infection, auto-immunity and failure of adaptation to stress are all in
doubt. According to Copeman (1964) "a number of factors may act as predis-
posing or precipitating agents in the presence of a soil rendered vulnerable by
genetic, environmental or metabolic influences ". There are, however, no external
factors known which could account for the large sex difference in rates of dying
from the disease. Lawrence (1961) calculated that the minimal prevalence of
the disease in Great Britain was 2 1 per cent in men and 5'2 per cent in women,
giving a sex-ratio similar to that of mortality found above. A genetic factor
in the extra X-chromosome would seem likely to account for the high female
susceptibility. It maybe noted that osteo-arthritis, osteitis deformans and chronic
diseases of the bones (723, 731, 733) show no such female excess at ages before
75 (index 98).
Chronic rheumatic heart (410-416) and other chronic endocarditis not involving
the aortic valves (421.0, 421-2, 421-3, 421.4). The first ofthese groups, comprising
deaths from chronic heart disease attributed by the certifier to rheumatic fever
and from lesions of the mitral valve with no cause stated on the certificate, shows
in TableII high female/male sex-ratios around 1-5 at every age (index 152). This
contrasts with acute rheumatism (400-402) for which there is a male excess at
every age under 70, and it is in even stronger contrast from chronic rheumatic
disease involving the aortic valve (index 39). The various subdivisions of deaths
classified as chronic rheumatic heart disease are distinguished in Table V where
sex-ratios in the ten years 1957-66 have been calculated, and in the same table
are shown acute rheumatism including chorea and the groups of other endocarditis
with acute myocarditis and pericarditis.
Mitral disease has the highest index of female susceptibility (180) with ratios
over 1F7 at each age under 75, but the small group with mitral involvement said
to be of non-rheumatic origin shows little sex difference at those ages. Aortic
valve disease affects males much more frequently than females, with indices of
39 for the deaths attributed to rheumatism as cause and 37 for the larger group of
those not so attributed. The three groups ofother chronic heart disease said to be
of rheumatic origin all show considerable female excess with indices of 131 for
endocarditis of the tricuspid or unspecified valve, 121 for myocarditis or peri-
carditis said to be rheumatic and 156 for the residual group of chronic rheumatic
heart not precisely described. The corresponding small groups of endocarditis
said to be of other than rheumatic cause and without mention of the mitral or
aortic valve show female excess at 45-54 and after 75 but no appreciable sex
difference at other ages (index 107).
Since active acute rheumatic fever produces higher death rates of males than
of females at every age (index 70), it is evident from the table that women are
peculiarly susceptible to chronic rheumatic affection of the mitral valve and men
to any affection of the aortic valve, the indices for these valvular involvements
differing very greatly in a proportion of about 5 to 1. Furthermore, since
myocardial and other forms of chronic rheumatic heart affection not involving
the aortic valve also show female excess with indices ranging from 122 to 156, the
mitral valve is not the only part of the heart which is more vulnerable to disease
among females.
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TABLE V.-Sex-ratios Between Mean Death Rates in 1957-60 in England and
Wales for Chronic Rheumatic Heart Disease, Other Endocarditis and Acute
Rheumatism
Categories of
heart disease
Mitral valve involved
Rheumatic or unstated
Non-rheumatic cause
Aortic valve, not mitral
Rheumatic cause.
Other or unspecified
Other chronic rheumatic
Endocarditis
Myocarditis, pericarditis
Heart, unspecified
Non-rheunatic cause specified
Endocarditis, except mitral or
aortic
Acute rheuMatism, active
Inter- No. of Female/male sex-ratios
national deaths,__ _ A Index
No. at 35+ 35- 45- 55- 65- 75+ 45-74
* 410 . 45728 . 1-73 1-87 1-80 1-72 1-60 . 180
. 421-0 . 2970 . - 054 0-83 1-13 1-47 . 83
* 411 4994 . 0 32 0 39 039 0-41 0-71
* 421-1 22399 . 0 24 0 27 029 0-54 0 80
* 412-4 . 3782 . 1-37 1-43 1-28 1-22 1-44
* 415 1215 . 096 1-22 1-26 1-18 1-61 .
. 416 . 11398 . 1-23 1-50 1-60 1-58 1-59 .
. 421-2- .
421*4
. 400-2 .
5286 . 1*02 1-23 0*98 1-01 1-16 . 107
730 . 0-89 0-92 0*57 0-60 0*73 . 70
Multiple sclerosis (345), from which there were 3207 deaths in England and
Wales in 1963-66 showed high female susceptibility at ages up to 65 with sex-
ratios of 1x61 at 35-44, 156 at 45-54 and 1-31 at 55-64, but no female excess after
that (index 127). By way of contrast paralysis agitans (350) has a male excess at
every age (index 73).
Subarachnoid haemorrhage (330) is shown in Table II to have a female excess
in the death rates during 1963-66 which increases with advancing age, the succes-
sive sex-ratios being 1-22 at 35-44, 1-27 at 45-64, 148 at 65-74 and 1F67 after 75
(index 134). This differs remarkablyfromothercerebralhaemorrhage,thrombosis,
embolism and ill-defined vascular lesions of the central nervous system as can be
seen in Table VI.
TABLE VI.-Sex-ratios Between Mean Death Rates in 1963-66 in England and
Walesfor Vascular Lesions Affecting the Central Nervous System
Category of disease
Subarachnoid haemorrage
Cerebral haemorrhage
Cerebral thrombosis and embolism
Other ill-defined vascular lesions
Inter-
national
No.
. 330
. 331
. 332
. 333-4 .
No. of
deaths
at 35+
14047
120310
145300
25604
Female/male sex-ratios
35- 45- 55- 65- 75+
1-12 1-30 1-24 1-48 1-67
. 0*77 0*99 0-81 0-86 1-02 .
1-03 0 67 0 62 0-72 0-94 .
. 0*70 0*62 0*54 0-65 0-86 .
The aggregate numbers of deaths at age over 35 were greater for women than
for men in each group, but that was due to the much larger female populations at
risk at advanced ages and is no guide to the relative death rates of the two sexes.
There were for example more deaths of women than of men from cerebral
haemorrhage at each age group after 45.
The index for subarachnoid haemorrhage at ages 45-74 was 134 compared
with 89, 67 and 60 for the other groups of cerebral lesions, and the high female
39
37
131
122
156
Index
at
45-74
134
89
67
60
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susceptibility to the subarachnoid variety can hardly arise from an external
cause and must be due to a tissue weakness peculiar to the female brain.
The geographical distribution of mortality from all forms of vascular lesions
of the central nervous system combined has been examined in another paper
(Stocks, 1968), but data were not available to allow distinction of subarachnoid
haemorrhage from other varieties.
Obesity (287) has a remarkably uniform sex-ratio exceeding 2 at each age and
an index of 224. The existence of such a steady level of female susceptibility
throughout life could hardly arise from extrinsic factors such as dietary peculiarities
ofwomen's habits for the differential effects on mortality ofthe sexes would surely
change with advancing age. It seems reasonable to attribute the cause to a
controlling influence over the endocrine glands emanating from the extra,
X-chromosome.
Pituitary and adrenal diseases (272, 274) were responsible in the ten years
1957-66 for mean annual death rates as depicted in Fig. 1 at ages 25 onwards, based
on 1688 deaths. Between 35 and 62 there was a pronounced excess of the female
rate but at the two ends of life males had the higher rates. The female/male
sex-ratio at ages 0-14 was 0-74, at 15-24 0-86 and at 25-34 0-82, but as seen in
Table II the ratios at the next three age groups were 1-59, 1-53, 1-15, falling again
below unity after 65. The high susceptibility ofwomen to diseases ofthese glands
between 35 and 55 arises presumably from the unusual demands on their activity
by women during that period of life, and it contrasts with the depressed female/
male ratio at 45-54 which has been noted for thyroid diseases.
Cancers of the pituitary and adrenals show no female excess in death rates at
45-74, the index in 1958-66 being 48 compared with 118 for other diseases of the
glands.
Cancer of the biliary passages (155-1-155.8) is one of the very few sites of
malignant neoplasms which shows evidence of female susceptibility, excluding
of course the breast and organs peculiar to women. Table II shows that the
female/male ratio between death rates in 1963-66 increased after age 40 to about
1-3 and then remained about that level (index 124).
Fig. 1 depicts the rates for each sex on a logarithmic scale. A similar pattern
appears for non-malignant diseases of the gall bladder and ducts which are dealt
with below.
The sex-ratios for primary cancer of the liver (155.0) are entirely different
from those for the biliary passages. In England and Wales the liver group shows
pronounced male excess with female/male ratios at age groups 35-44 onwards
0-43, 0-42, 0-40, 0-45, 0-56 compared with 0 59, 1'07, 1-36, 1-29, 1-30 for the duct
cancers. For the two categories combined the ratios are close to unity in Great
Britain but not in Ireland as a whole where the death rates in 1954-61 showed
female excess at each age with indices about 125 as may be seen in Table VII.
No reason for the female susceptibility in the two parts of Ireland but not in
Great Britain can be suggested, but the Netherlands has a very high index of 147
and the German Federal Republic 130. The Scandinavian countries, France,
Switzerland and Italy show, like Great Britain, no female excess, but Austrian
ratios show a U-shaped trend with female excess at the two ends oflife (index 106).
Separation of primary liver cancer from malignant neoplasms of the gall
bladder and bile ducts, not possible from the available data of the countries in
Table VII, has been made below for death rates in cities of Latin America and for
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FIG. I.-Death rates for each sex in England and Wales from cancer of thyroid 1950-63,
and bile ducts 1963-66, other diseases of pituitary and adrenals 1957-66.
(a) Cancer of thyroid.
(b) Cancer of gall bladder and bile ducts.
(c) Diseases of pituitary and adrenal (non-malignant).
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TABLE VII.-Sex-ratios of Death Rates in 1954-66 for Cancers of the Liver
and Biliary Passages Combined in Parts of Europe
Female/male ratios at ages
Index
Country 35- 45- 55- 65- 75+ 45-74
England and Wales 0 92 0 88 0 83 0-93 1-05 88
Scotland . . 096 0 94 0 87 1 00 101 . 94
Northern Ireland 1-66 1-29 1-33 1-12 1-27 . 125
Eire (Irish Republic) 099 1-21 1.19 1-31 0 88 124
Scandinavia . 0 95 0 84 091 1.01 1-03 92
Netherlands . . 0 78 1-34 1-47 1-61 1-62 149
Germany, F.R. 00 1-32 1-28 1-32 1-47 . 130
Austria . -49 1909 095 1-14 1-29 106
France . 101 0 78 0 72 0 79 0 98 76
Switzerland 1-33 1-03 0 95 0 65 1- 06 88
Italy . 090 0 84 0 84 095 1 09 88
morbidity rates extracted from cancer registration records in Denmark, Norway,
Israel and Connecticut, the ratios expressing female in terms of male rates.
In 1962-64 clinical and post-morten investigations were made of the persons
aged 15-74 who died in 10 Latin American cities and in Bristol and San Francisco,
169 of the deaths being classified as due to primary cancer of the liver and 295 as
cancer of the biliary passages (Puffer and Wynne Griffith, 1967). The sex-ratios
between the age-adjusted rates (with numbers of deaths in parentheses) were as
follows: Primary liver 0-55; total biliary passages 1F96; gall bladder 4-50 (134);
bile ducts 1-14 (58); ampulla of Vater 0-67 (31); site not determined 2-0 (72).
From the cancer register in Copenhagen average sex-ratios for Denmark in
the 15 years 1943-57 (Clemmesen, 1964) were for the four age groups 35-44,
45-54, 55-64, 65-74; Primary liver 1F03; Biliary passages 2-37. From
Connecticut in 1947-51 (Griswold et al., 1955) the corresponding ratios were
0*65 and 1*82. Cancer registration in Norway (Norwegian Cancer Society, 1964)
showed for the whole country in 1959-61 average sex-ratios at 45-54, 55-64 and
65-74 of 0-64 and 1-48 for the two cancer groups. In Israel in 1960-64 (Steinitz,
1967) the standardised rates at ages over 15 in the total Jewish population gave
sex-ratios of 0-54 and 3 10 for those groups.
It is evident from the above that the female vulnerability to cancer of the
biliary passages which was indicated by mortality in England and Wales is not
accounted for by fatality differences but is even more pronounced in incidence
rates, and the figures confirm that primary cancer ofthe liver is much more frequent
in occurrence among males.
Cancer of the pancreas (157) shows no female excess in England and Wales,
the ratios in 1963-66 at the 5 age groups being 0-58, 0-56, 0-56, 058, 0-69 (index 56).
Diseases of the gall bladder and bile ducts (584-586), and of the liver (except
cancer and cirrhosis) (580, 582, 583).-Liver diseases except cirrhosis and cancer,
consisting mainly of acute forms of hepatitis not included among the infective
diseases, show a female excess (ratio 1-26 at ages 45-54) but no appreciable excess
at other ages as seen in Table II (index 109). Gallstones and infective conditions
of the biliary passages manifest, however, a female susceptibility with sex-ratios
about 1-45 at ages up to 65 falling to 1-2 or 1.1 at later ages (index 137). For
cancer of those organs the female excess appeared after 45 as already noted. No
reason for the vulnerability of women to gall bladder affections in particular is
known unless tight clothing could be a factor.
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In the Latin American cities in 1962-64 referred to in the section on cancer of
the liver complex there were 381 deaths from cholelithiasis and cholcystitis and
the sex-ratios at ages 35-44, 45-54, 55-64 and 65-74 were 2*00, 1*76, 1*81, 1*91
(index 185), an even greater female excess than in England and Wales.
Pancreatic diseases except cancer show no female excess, except at advanced
ages for acute pancreatis, the sequence of sex-ratios for that cause in England
and Wales being 051, 072, 0-94, 088 at ages 35-74 increasing suddenly to 136
at ages over 75 (index 85).
Cancers of the intestine (152, 153) and of the rectum (154).-In the Registrar
General's Statistical Review for 1935 (Registrar General, 1938) the death rates in
1911-20, 1921-30 and 1931-36 were seen to produce sex-ratios for cancer of the
rectum which differed remarkably from those for cancer ofthe rest ofthe intestine.
In his Table LXV the female/male ratios between standardised rates at all ages
in the three periods were 0-63, 0-48 and 0-52 for the rectum, indicating pronounced
female immunity whereas for other intestine they were 1'13, 1*04 and 1 00
indicating a small female excess which had disappeared by 1931-36. Ashley
(1969) has again drawn attention to this curious difference which still persists
in mortality statistics. Some changes in rules ofclassification of " recto-sigmoid "
have occurred but there is no reason why they should affect the rates for the two
sexes differently.
Table II shows that in 1963-66 thefemale/male ratio for cancer ofthe intestines
excluding rectum was 1-20 at ages up to 54, falling to 1*05 at 55-64 after which
there was no female excess (index 105). For the rectum however the sequence
from 35-44 onwards was 0-92, 0-78, 0-64, 0-39, 0 55 (index 60), and this male
excess is similar to that found in the upper digestive tract. Thus, as Wynne
Griffith (1968) has shown by analysis of stomach cancer rates in 1958-63 in 24
countries, the female/male ratios in England and Wales fell regularly from 0-62 at
35-39 to 0-38 at 55-59 and then increased to 0-71 at 80-84 (index 45). For the
oesophagus in the same period the ratio was 0-85 at ages 35-44 falling to 0*47 at
60-64 and remaining about that level. For the mouth and pharynx the ratios
were 1.05 at 35-44, 0-91 at 45-49, and at subsequent 5-year groups 0 77, 0-63, 0-51,
0-38, 0-31, 0-26, 0-22 (index 58).
The reason for the contrast between the intestine from duodenum to sigmoid
with its slight female excess in death rates up to age 65 and the large male excess
for the rest of the digestive tract is obscure. That it was present throughout
northern Europe is evident from the mean sex-ratios of female to male mortality
during 1954-61 set out below for cancer of the intestine excluding the rectum
(Table VIII). As was the case for cancer of the biliary passages the Netherlands
showed the greatest female excess at every age after 45.
TABLE VIII. Mean Sex-ratios ofFemale to Male Mortality 1954-61 for
Cancer ofIntestine, Excluding Rectum
Mean of sex-ratios of component
countries in 1954-61
Index
35- 45- 55- 65- 75+ 45-74
British Isles 1-54 1-28 109 091 1.01 109
Scandinavian countries 1-08 1-20 1-03 0 95 1-02 106
Netherlands . . . 1- 12 1-40 1- 24 1- 09 1- 29 124
Belgium . 1- 17 1- 17 109 1.01 1-17 109
Mid-European countries . 1-07 1 01 0 86 0 83 1.08 . 90
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In Britain and Belgium there was pronounced female excess up to 65 and in
Scandinavia up to 55, but the countries of mid-Europe (France, Germany, Austria,
Switzerland, Italy) showed no such excess in the middle age groups.
Anaemias, purpura and diseases of the spleen (290-293, 296, 298, 299) all show
evidence of female susceptibility at all ages in 1963-66 in England and Wales
with high sex-ratios of 1P65 at 35-44 and 1P45 at 45-54, followed by a moderate
excess about 1P20 after 55 (index 127). This is connected no doubt with the
function of child bearing and needs no special comment.
Diseases of the veins and embolism (460-466) show pronounced female excess of
mortality at ages 35-44 and a small excess at 45-54, probably due to delayed
results of child bearing. At later ages there is some excess at 75 and over but
none at the intervening ages (index 100).
Asthma (241) in 1963-66 presented an excess in female death rates from age
15 to 65, the successive sex-ratios at age groups from 15-24 onwards being 1X20,
1X19, 1X54, 1-31, 1I10, 0*86, 0-54 (index at 45-74 109). This is in sharp contrast
with bronchitis which showed a high degree of female immunity relative to males
(ratios at the same ages 0-65, 0-72, 0-60, 0-28, 0-17, 0419, 0*31, and index 21).
According to the definition of asthma in the International List as used in 1963-66,
any mention of bronchitis on a death certificate along with asthma causes the
death to be classified to the former disease and since such association is more
frequent among men a larger proportion of deaths mentioning asthma are
assigned to bronchitis (500-502) for that sex. This might account for the high
sex-ratios suggesting female vulnerability at ages under 65, which may be an
artefact, and the inclusion of asthma in TableII is of doubtful validity. It may
be noted that owing to the difficulty of disentangling the two conditions as cause of
death asthma has been transferred from the "allergic " group to become a
subdivision of bronchitis in the 1968 revision of the international list.
Malignant melanoma of the skin (190) shows female excess in death rates in
1963-66 with a sex-ratio of 1-27 at 35-44, falling to around110 between 45 and 74
and to unity at 75 and over (index 109). Other skin cancer shows a male excess
and in all countries this is true of total skin cancer. In a series of111 patients
treated in South Wales for melanoma, all of them Caucasians, the female excess
was found to be confined to lesions on the lower limbs (Jones et al., 1968).
Diabetes mellitus (260).-Death rates from this disease in England and Wales
show significant regional differences and the sex-ratios are by no means the same
in the north as in the south. In Table IX division is made into three groups of
the 15 hospital regions: North west (comprising Manchester, Liverpool, Leeds,
Newcastle and Welsh hospital regions); Central (Sheffield, Birmingham, East
Anglia, North East Metropolitan and North West Metropolitan regions); Southern
(South western, Oxford, Wessex, South west Metropolitan and South east
Metropolitan regions). The mean annual death rates in 1963-66 are given for
each group and for comparison with the northern group the rates in Scotland
for 1954-61 are also shown.
The comparisons in Table IX reveal some curious facts about the distribution
of mortality from diabetes by sex and age within Great Britain. (1) Death rates
of men in England and Wales increased between 1954-61 and 1963-66 by about
one third at ages 35-64 and one quarter at ages over 65, whereas those of women
remained steady at 35-64 and increased slightly after 65. (2) Death rates of men
in the north west of England and Wales in 1963-66 were about 10 per cent higher
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TABLE IX.-Diabetes Mortality by Sex and Age in 3 Areas ofEngland
and Wales (1963-66) and in Scotland, England and Wales (1954-61)
Males Females
35- 45- 55- 65- 75+ 35- 45- 55- 65- 75+
England and Wales 1963-6
Mean annual rNorth west 22 34 98 304 799 . 10 28 144 520 908
raes
anna Central . 19 36 114 329 732 . 11 25 113 415 890 rates per
m South .18 34 83 273 763. 9 24 91 335 761
million 1tAll regions . 20 35 99 304 742 . 10 26 117 426 853
North west . . 0-44 0-82 1-47 1- 71 1- 13
Ratio to Central . . 0-60 0-70 0-99 1-26 1-22
male rate South . . 0-49 0-72 1-10 1-22 1- 10 IAll regions . . 0-51 0- 75 1-08 1-40 1- 15
Ratio of rDeath rates 1-20 1-02 1-18 1-11 1-05 1-22 1-16 1-55 1-55 1-19
North-west Sex-ratios . . 0-90 1-14 1-34 1-40 1-13
to South L
England and Wales 1954-61
Rates per million . 15 27 76 261 605 . 10 28 125 397 731
Ratio to male rate . . . 0-67 1-05 1-65 1-52 1-21
Scotland 1954-61
Rate per million . . 18 42 109 337 622 . 16 43 277 717 963
Ratio to male rate . 0-93 1-04 2-53 2-13 1-55
Ratio to England & Wales. 1-20 1-56 1-43 1-29 1-03 . 1-60 1-54 2-22 1-81 1-32
than in the south, whereas among women the north west excess was 55 per cent
at 55-74 and about 20 per cent at other ages. (3) Death rates of men in Scotland
in 1954-61 were about 50 per cent higher than in England and Wales at ages 45-64
and about 25 per cent higher at 35-44 and 65-74, whereas among womenthe excess
was about 50 per cent at 35-54, 100 per cent at 55-74 and 30 per cent at 75 and
over. (4) After allowing for the rise in death rates noted in (1) and assuming
that the Scottish rates behaved in the same way, the differences between Scotland
and Southern England when expressed in terms of the latter taken as 100 for the
successive age groups were 28, 47, 59, 29, 0 for men whereas the northern excess
was much greater for women, namely 77, 71, 195, 123, 42. (5) There is therefore
a pronounced upward gradient in mortality from south to north in Great Britain,
stronger among women at every age and particularly at ages 55-74. (6) The
sex-ratios show male preponderance in all parts of England and Wales at ages up
to 54, then changing to a female excess which is very pronounced in the north
west at 55-74 with ratios around 1-6 but only slight in the rest of England. In
Scotland the female susceptibility at ages 55-74 is still more evident with ratios
about 2-3.
Theregional comparison is depicted inFig. 2, andthe pattern is more suggestive
of differential action of extrinsic factors on the sexes than of genetic differences
in female susceptibility to diabetes. Thus the explanation might lie in a larger
ingestion of sugar and other carbohydrates by middle aged women compared with
men in the northern parts of Britain than in the south.
In Table X sex-ratios are shown at the five age groups between diabetes
death rates in 1954-61 in 26 countries arranged in ascending order of the index at
45-74. In the first two, Ceylon and Portugal, there was no appreciable female
excess at any age, and in the next, Japan, it was not present after 55. In the
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ratios see Table IX, dividing death rates by 10.)
other 23 countries the predominant picture is a sudden change from male to female
excess at 55, exceptions being Australia, U.S. Whites, England and Wales,
Scotland, Netherlands, Belgium, Hungary and Israel where the change occurred
earlier at about 45, and Colombia, Venezuela and U.S. Non-whites, where it had
already occurred at 34. This means that in 23 of the 26 countries there was a
female excess at every age after 55. The sudden change from male to female
preponderance was in most cases very pronounced and subsequent changes after
55 were only slight. The most interesting age period for comparing the countries
was 45-54 at which age Great Britain and Australia had developed slight female
excess, Hungary and Venezuela showed about 15 per cent and Colombia, U.S.A.,
Netherlands, Belgium and Israel already had large female excess. In Ireland, Scandinavia, Central Europe except Hungary, Canada and New Zealand however
men still had the highest death rates at this age period. The ten Latin America
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cities studied in 1962-64 (Puffer and Wynne Griffith, 1967) didnot showanyfemale
excess until age 55 except in Cali and Sao Paulo.
The reasons for these geographical differences are obscure but some peculiarity
in dietary habits of women before 55 in the Low countries, U.S.A., Colombia,
Venezuela and Israel, appearing later in other countries, may account for them.
TABLE X.-Diabetes Sex-ratios Between Mean Annual Death Rates of Females
in 1954-61 and those of Males in 26 Countries Ranked in Order of the Average
Ratio at Ages 45 to 74
Index
35- 45- 55- 65- 75+ at 45-54
Ceylon . . . . 0-83 0-91 . 0 75 . 0-58 . 0 36 . 75
Portugal . . . 0-67 . 0-95 . 0-91 . 1-03 . 0-91 . 96
Japan . . . . 1-30 1-04 . 0-94 . 0-95 . 0-76 . 98
France . . . . 0-75 0-83 . 1-19 . 1-28 . 1-25 . 110
Ireland (Eire) . . . 0-86 . 070 . 1-31 . 1-32 . 1-20 . 111
Italy . . . . 083 . 0-85 . 1-36 . 1-31 . 1-26 . 117
Norway . . . . 059 . 0-61 1-37 . 1-53 1-49 . 117
Sweden . . . 0-62 0-70 . 1-29 . 1-56 . 1-23 . 118
Denmark . . . 0-51 . 0-68 . 1-51 . 1-52 . 1-17 . 124
Northern Ireland . . 1-27 . 0-88 . 1-66 1-28 . 1-20 . 127
Austria . . . 0-42 . 0-97 . 1-36 . 1-57 . 1-73 . 130
Australia. . . 0-95 . 1-04 . 1-31 . 1-56 142 . 130
New Zealand . . . 0-38 . 0-94 . 1-34 . 1-64 1-03 . 131
Switzerland . . . 1-14 . 0-94 . 1-43 . 1-57 . 1-49 . 131
Germany, F.R. . 0-78 . 0-96 . 1-49 1-53 . 1-52 . 133
U.S.A. (VVhite) . . 0-63 . 1-57 . 1-14 . 1-49 . 1-25 . 133
Canada . . . 0-49 0-96 . 1-55 . 1-50 . 1-26 . 134
Colombia . . . 1-20 . 1-49 . 1-34 . 1-31 . 1-17 138
Hungary . . 0-91 . 1-18 . 1-45 1-58 . 1-66 . 140
England and Wales . 0-67 . 1-05 1-65 . 1-52 1-20 . 141
Israel . . . . 0-50 1-71 . 1-50 . 1-11 . 1-09 . 144
Finland . . . 063 . 0-75 . 1-55 2-11 . 250 . 147
Venezuela . . . 1-03 1-15 . 2-11 2-02 1-25 . 176
Netherlands . . 0-86 1-47 . 1-73 . 2-20 . 1-93 . 180
Belgium . . . 0-82 1-88 . 1-77 . 1-89 1-71 . 185
Scotland. . . . 0-93 . 1-04 . 2-53 . 2-13 1-55 190
U.S.A. (Non-white) . . 1-42 . 2-15 . 2-21 . 1-71 1-49 . 202
Deaths due to violence.-There are a few accidental causes of death to which
women of certain ages are more prone than men, and although the reasons for it
are plain they are shown in Table XI in order to complete the record. For
utility gas poisoning and falls from one level to another the excess of female
TABLE XI.-Sex-ratiosfor Death Ratesfrom Violent Causes in 1963-66
Showing a.Female Excess, in England and Wales
Inter- No. of Sex-ratio female/male at ages
national deaths A
Kind of accident No. at 35+ 35- 45- 55- 65- 75- 85+
Poisoning byutility gas . . . E890 . 3613 . 1-56 0-57 0-69 1-00 1-08 1-04
Fall from one level to another . . E902 . 1768 . 0-92 0-16 0-14 0-46 0-87 1-09
(not stairs)
Fall on same level . . . E903 . 10979 . 0-45 0-50 0-78 1-27 1-49 1-56
Fall, kind unspecified . . . . E904 . 4789 . 0-36 0-49 1-10 1-48 1-72 1-61
Fire or explosion of combustible E916 2301 . 0-63 1-16 1-39 1-49 1-23 0-88
material
23
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liability to a fatal issue appears only in very advanced age, and for other falls it is
seen after about 60. There is an excess of fire risk for women at all ages from 45
to 84.
SUMMARY
Death rates from a small proportion of the causes in the International
Classification are higher among women than among men at the same ages, and
the amount of female susceptibility and the ages at which it is present in England
and Wales and other countries is investigated for such causes by means of the
sex-ratios.
In the 24 groups of causes involved are four sites of cancer (excluding the
breast and organs peculiar to females), namely the thyroid, biliary passages,
intestine other than rectum and melanoma of the skin, and for the first two of
these the sex-ratios are compared with those for other diseases ofthe same organs.
Geographical differences are pronounced for cancers of the thyroid, biliary
passages and intestine, and also for diabetes. For some of the causes of death
extrinsic factors or childbearing can account for the greater susceptibility of
women but for most ofthe others it is concluded that differences in genetic control
emanating from the extra X-chromosomes probably account for greater vulnera-
bility of females to disease in certain tissues such as the thyroid glands and the
gall bladder.
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